John O’Rourke

John has over 20 years’ of experience in the research, testing and development of tools and therapeutics for the oncology space. In his role as CEO & President, John is leading a team of scientists in developing novel applications and reagents for BennuBio’s Velocyt technology. Prior to joining BennuBio, John was the Head of Product Development for Intellicyt/Sartorius leading the R&D team in the commercialization of reagent, software and hardware solutions for the high throughput flow cytometry community.